AnGes

Aiming to be a global leader in genetic medicine

Takeda Pharmaceuticals

Better Health, Brighter Future

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.

AVROBIO

What if one gene can change your entire world?

JCR Pharmaceuticals

JCR Pharmaceuticals Co., Ltd. is a global specialty pharmaceuticals company that is redefining expectations and expanding possibilities for people with rare and genetic diseases worldwide. Our core values – reliability, confidence, and belief – means that the work we do benefits all our stakeholders, including employees, partners, and patients.

We continue to build upon our 46-year legacy in Japan while expanding our global footprint with trials in the US, Europe, and Latin America. We improve patients’ lives by applying our scientific expertise and unique technologies to research, develop, and deliver next-generation therapies. If you are interested in speaking with JCR regarding business development opportunities visit our website at https://congress.jcrpharm.co.jp 

BioMarin

Pioneers in Rare Disease

Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and life-threatening conditions where we can significantly improve upon the current standard of care.

Traffic

Traffic is a monthly, peer-reviewed, scientific journal, which was established in 2000, and is published by Wiley-Blackwell. The online version is at the Wiley Online Library. This journal is co-edited by Eric Chevet, Antonella De Matteis, Eeva-Liisa Eskelinen, and Hesso Farhan. The journal covers all aspects of signal transduction (intracellular transport) in health and disease, for both mammalian and non-mammalian biological systems.

Ultragenyx

Our Rare Formula

Relentless dedication to serving patients with serious rare and ultra-rare genetic diseases

At Ultragenyx, we have a unique formula for drug development that reflects our shared urgency to accelerate the timelines for delivering safe and effective new medicines to patients.